Thursday, November 05, 2020 8:21:11 PM
Many brokerage firms have already submitted their reports for BNGO stocks, with Ladenburg Thalmann repeating the rating for BNGO by listing it as a “Buy.” The predicted price for BNGO in the upcoming period, according to Ladenburg Thalmann is $1.25 based on the research report published on September 24th of the current year 2020.
Oppenheimer, on the other hand, stated in their research note that they expect to see BNGO reach a price target of $1.50. The rating they have provided for BNGO stocks is “Outperform” according to the report published on April 08th, 2020.
Recent BNGO News
- Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024 • GlobeNewswire Inc. • 05/01/2024 12:00:00 PM
- Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference • GlobeNewswire Inc. • 04/30/2024 08:05:00 PM
- Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing • GlobeNewswire Inc. • 04/24/2024 12:00:00 PM
- Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence • GlobeNewswire Inc. • 04/17/2024 12:00:00 PM
- Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 04/04/2024 05:44:35 PM
- Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys™ System at the American Association for Cancer Research Annual Meeting • GlobeNewswire Inc. • 04/02/2024 12:00:00 PM
- Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance • GlobeNewswire Inc. • 03/19/2024 12:00:00 PM
- Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ System • GlobeNewswire Inc. • 03/07/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:48:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:47:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:46:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:44:40 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 10:26:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:23:48 PM
- Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024 • GlobeNewswire Inc. • 03/05/2024 09:01:00 PM
- Bionano to Present at TD Cowen’s 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 01:16:10 PM
- Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024 • GlobeNewswire Inc. • 02/28/2024 01:01:00 PM
- Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway • GlobeNewswire Inc. • 02/28/2024 01:00:00 PM
- American College of Medical Genetics and Genomics Includes OGM in Latest Edition of Technical Laboratory Standards for Solid Tumor Analysis • GlobeNewswire Inc. • 02/22/2024 01:00:00 PM
- Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference • GlobeNewswire Inc. • 01/31/2024 01:00:00 PM
- Bionano’s Symposium 2024 Featured Presentations from its Global User Community Highlighting OGM as a Powerful Alternative to Classical Cytogenetics and Strong Complement to NGS • GlobeNewswire Inc. • 01/30/2024 01:00:00 PM
- Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing • GlobeNewswire Inc. • 01/24/2024 01:00:00 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM